Lucas de Breed
Directeur/Bestuurslid bij InteRNA Technologies BV
Oorsprong van het eerstegraads netwerk van Lucas de Breed
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
INKEF Capital BV
INKEF Capital BV Investment ManagersFinance INKEF Capital BV is an Independent Venture Capital firm founded in 2010 by Frank R Landsberger. INKEF Capital BV is headquartered in Amsterdam.
19
| Private Company | Investment Managers | 19 |
InteRNA Technologies BV
InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands.
9
| Holding Company | Biotechnology | 9 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Lucas de Breed via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
Nyenrode Business Universiteit | College/University | Masters Business Admin Graduate Degree | |
Top Institute Pharma
Top Institute Pharma BiotechnologyHealth Technology Part of Center for Translational Molecular Medicine, Top Institute Pharma provides pharmaceutical research services. The company is based in Leiden, Netherlands. Top Institute Pharma was acquired by Center for Translational Molecular Medicine on June 09, 2015. | Biotechnology | Director/Board Member | |
SYNCONA LIMITED | Investment Trusts/Mutual Funds | Private Equity Investor | |
NIBC Principal Investments BV
NIBC Principal Investments BV Investment ManagersFinance NIBC Principal Investments BV (Principal Investments) is a subsidiary of NIBC Bank NV, ultimately owned by Kaupthing Bank HF (RE: KAUP) in Iceland. Established in 2003, Principal Investments is a private equity firm which provides mezzanine and private equity financing to companies in Western Europe, particularly in the Benelux countries, Germany and the UK. The firm's activities include direct investments, providing capital for mid-cap companies in Western Europe as well as in real estate and infrastructure projects in Western Europe. They invest as a limited partner in funds managed by NIBC and third parties. | Investment Managers | Private Equity Investor | |
Aveni SA
Aveni SA Chemicals: Major DiversifiedProcess Industries Aveni SA designs, develops, manufactures and markets chemical formulations. It enables future technologies with its approach to metallization for semiconductor, MEMS, advanced packaging, and flex applications. The company was founded in 2001 and is headquartered in Massy, France. | Chemicals: Major Diversified | Director/Board Member | |
University of Leiden | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
University of Utrecht | College/University | Doctorate Degree Corporate Officer/Principal | |
Radboud University Nijmegen | College/University | Doctorate Degree Doctorate Degree | |
Biogeneration Management BV
Biogeneration Management BV Investment ManagersFinance Biogeneration Management is a venture capital firm, a subsidiary of BioGeneration Holding BV and was founded in 2006. Biogeneration management is headquartered in Naarden. | Investment Managers | Private Equity Investor | |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Medical Specialties | Corporate Officer/Principal | |
Ontwikkelingsmaatschappij Oost Nederland NV
Ontwikkelingsmaatschappij Oost Nederland NV Investment ManagersFinance Ontwikkelingsmaatschappij Oost Nederland NV (Development Agency East Netherlands) is an Independent Private Equity/Venture Capital firm that focuses its activities on strengthening the economy of the provinces of Gelderland and Overijssel, the Netherlands. Oost NV is headquartered in Apeldoorn. | Investment Managers | Private Equity Investor | |
Genzyme Europe BV
Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | Sales & Marketing | |
Organon International BV | President | ||
HANSA BIOPHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
Holland Private Equity BV
Holland Private Equity BV Investment ManagersFinance Holland Private Equity BV is a private equity and venture capital firm. The firm was founded in 2008 by Tim van Delden and Hans van Ierland. It’s headquartered in Amsterdam, the Netherlands. | Investment Managers | President President | |
Complix NV
Complix NV Pharmaceuticals: MajorHealth Technology Complix NVengages in the development of biopharmaceutical company developing Alphabodies, a pipeline of transformative protein therapeutics. The Company is currently focusing its internal research and development activities on oncology and autoimmune diseases. Its therapeutic Alphabodies focuses on the treatment of autoimmune diseases, such as rheumatoid arthritis, psoriasis and multiple sclerosis, and infectious diseases, and viral diseases such as influenza, HIV, and RSV. The company was founded by Mark Vaeck and Ignace Lasters in 2008 and is headquartered in Diepenbeek, Belgium. | Pharmaceuticals: Major | Chairman | |
Hubrecht Institute
Hubrecht Institute BiotechnologyHealth Technology The Hubrecht Institute is a research institute that focuses on fundamental, multidisciplinary research on healthy and diseased cells, tissues, and organisms. The location of the private company is in Utrecht, Netherlands. The institute encompasses 23 research groups dedicated to this mission. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member | |
Shapeways, Inc.
Shapeways, Inc. Commercial Printing/FormsCommercial Services Shapeways, Inc. provides on-demand 3D printing services. The firm specializes in personalized manufacturing, mass customization, personalized production and digital fabrication. The company was founded by Robert Schouwenburg, Peter Weijmarshausen and Marleen Vogelaar in 2007 and is headquartered in New York, NY. | Commercial Printing/Forms | Director/Board Member | |
VICORE PHARMA HOLDING AB | Pharmaceuticals: Major | Chairman | |
Convent Capital Management BV
Convent Capital Management BV Investment ManagersFinance Convent Capital Management BV is an independent private equity firm with its headquarters in Amsterdam, the Netherlands. It was founded in 2011. | Investment Managers | Director of Investments | |
Aito BV
Aito BV Information Technology ServicesTechnology Services Aito BV provides piezo touch user interface technology. It offers touch solutions on real physical user interfaces with buttons, touch pads, and screens. The firm's products include touch demos that recognize a human touch through various overlay materials, including stainless steel, aluminum, wood, and polycarbonate with back light; whole switching units with injection molded housing, electronic design, and touch user interfacing; aluminum and steel amplifier touch devices. The company was founded by Rene de Vries, Pauli Laitinen and Jockum Lonnberg in 2012 and is headquartered in EJ Amsterdam, the Netherlands. | Information Technology Services | Director/Board Member Director/Board Member | |
Top Sector Life Sciences & Health | Director/Board Member | ||
Asceneuron SA
Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Chairman Chairman | |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
PHARVARIS N.V. | Pharmaceuticals: Major | Founder | |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
EclecticIQ BV
EclecticIQ BV Information Technology ServicesTechnology Services EclecticIQ BV develops cyber threat intelligence platform. The company was founded by Joep Gommers and Raymon van der Velder in 2014 and is headquartered in Amsterdam, the Netherlands. | Information Technology Services | Director/Board Member Director/Board Member | |
NMD Pharma A/S
NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Biotechnology | Director/Board Member Director/Board Member | |
Merck Ventures BV
Merck Ventures BV Investment ManagersFinance Merck Ventures BV (Merck Ventures) is a venture capital arm of Merck KGaA founded in 2009. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Nefarma | Director/Board Member | ||
Varmx BV
Varmx BV BiotechnologyHealth Technology VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018. | Biotechnology | Director/Board Member | |
Scenic Biotech BV
Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Scenic Biotech BV is using genomics to develop innovative therapies for patients affected by severe diseases. The company was founded by Thijn Brummelkamp and Sebastian Nijman and is headquartered in Amsterdam, Netherlands. | Miscellaneous Commercial Services | Director/Board Member | |
iOnctura SA
iOnctura SA Miscellaneous Commercial ServicesCommercial Services iOnctura SA is a pre-clinical stage biopharmaceutical company focused on the research and development of novel immuno-oncology therapeutics for patients fighting cancer. The company was founded in June 2017 and is headquartered in Geneve, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Salvia BioElectronics BV
Salvia BioElectronics BV BiotechnologyHealth Technology Salvia BioElectronics BV develops a bioelectronics therapy for people suffering from chronic neurological diseases. The company was founded by Sjaak Deckers and Hubert Martens in 2017 and is headquartered in Eindhoven, the Netherlands. | Biotechnology | Director/Board Member | |
Ciwit BV
Ciwit BV Internet Software/ServicesTechnology Services Ciwit BV provides electronic data capture platform for medical research. The company was founded by Derk Arts in 2011 and is headquartered in Amsterdam, the Netherlands. | Internet Software/Services | Director/Board Member Director/Board Member | |
INIM Pharma AB
INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Waterman 40 Holding BV
Waterman 40 Holding BV Investment ManagersFinance Waterman 40 Holding BV (Waterman 40 Holding) is an Independent Private Equity/Venture Capital firm founded in 2015. The firm is headquartered in Maarsbergen. | Investment Managers | Private Equity Investor | |
Alveron Pharma BV
Alveron Pharma BV Pharmaceuticals: MajorHealth Technology Alveron Pharma BV is a Dutch company that develops cyclodextrin-based drugs. The company is based in Nijmegen, Netherlands. The company was founded in 2019. Ben Nichols has been the CEO of the company since 2019. | Pharmaceuticals: Major | Director/Board Member | |
River Biomedics B V I.O.
River Biomedics B V I.O. Medical SpecialtiesHealth Technology River Biomedics B V I.O. is a Dutch biotech company that focuses on cardiac drug discovery. The company is based in Enschede, Netherlands. The company develops novel therapies for cardiac diseases by directly targeting the heart muscle using human predictive 3D in-vitro models and human induced pluripotent stem cell (hiPSC) technology. The company aims to address high unmet medical needs and provide detailed clinically relevant read-outs through high-throughput in-house screening platforms. River Biomedics values partnerships and strives for novelty by mimicking nature and connecting biology and engineering. The company was founded by Marcelo Ribeiro, Robert Passier, Lisanne Blauw, and the CEO is Nicky Cooper. | Medical Specialties | Director/Board Member | |
F-STAR THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ONWARD MEDICAL N.V. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
SHAPEWAYS HOLDINGS, INC. | Commercial Printing/Forms | Director/Board Member | |
Kersten Elektrotechniek BV
Kersten Elektrotechniek BV Engineering & ConstructionIndustrial Services Kersten Elektrotechniek BV is a Dutch company that specializes in engineering, realization, prefab, project management, and management of complete installations. The private company is based in Elst, Netherlands. The company has everything in-house, from design and engineering to project management and technical management, which allows them to complete installations with their partners. The CEO of the company is Jan Pieter Manschot. | Engineering & Construction | Director/Board Member | |
Phlox Therapeutics BV
Phlox Therapeutics BV BiotechnologyHealth Technology Phlox Therapeutics BV is a Dutch company that develops gene therapy to alleviate and cure cardiomyopathies. The company is based in Naarden, Netherlands. The company was founded by Yigal M. Pinto, Eva van Rooijen. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
Nederland | 31 |
Verenigde Staten | 6 |
Zweden | 6 |
Zwitserland | 5 |
Verenigd Koninkrijk | 4 |
Sectoraal
Health Technology | 24 |
Finance | 9 |
Commercial Services | 7 |
Consumer Services | 5 |
Technology Services | 4 |
Operationeel
Director/Board Member | 81 |
Private Equity Investor | 30 |
Corporate Officer/Principal | 20 |
Chief Tech/Sci/R&D Officer | 15 |
Independent Dir/Board Member | 11 |
Sterkste connecties
Insiders | |
---|---|
Roel Bulthuis | 29 |
Johannes G. C. P. Schikan | 22 |
Fiona MacLaughlin | 22 |
Graham Dixon | 18 |
Andrea van Elsas | 16 |
Dirk Kersten | 14 |
Robert Galema | 8 |
Roel Q. J. Schaapveld | 7 |
Corné Jansen | 6 |
Edwin Cuppen | 5 |
Michael Stam | 5 |
Brian S. Bronk | 5 |
Rianne Ellenbroek | 4 |
Brigitte van der Maarel | 4 |
Samuel Gerssen | 3 |
- Beurs
- Insiders
- Lucas de Breed
- Bedrijfsconnecties